Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessA phase II clinical trial to investigate the effect of pioglitazone on 18F-FDG uptake in malignant lesions
We found that 18F-2-fluoro-2-deoxy-D-glucose (18F-FDG) uptake in malignant lesion was enhanced, and it was decreased in the inflammatory lesion after the use of peroxisome proliferator activated receptor-γ (PPAR-...
-
Article
Before and after treatment 18F-FDG PET/CT images in a patient with cutaneous T-cell lymphoma